Regulatory Agencies

FDA MHRA Drug Safety Drug Approval Process Food and Drug Administration Anvisa Drug Approval Food and Drug Administration (FDA) ANMAT UK Health Security Agency

Houston Compounder Recalls Injectable Wellness Products Over Endotoxin Contamination

The recall forces patients to discard affected doses, highlighting gaps in oversight of customized medicines.

UK Regulator Authorizes Foundayo, an Oral Once‑Daily GLP‑1 Pill

FDA Advisers Back 2026–27 Flu Shot Overhaul to Target Dominant H3N2 Variant

MHRA Issues Safety Guidance for Mental Health Apps, Launches NHS Resources

MHRA Launches Free Guidance to Help People Assess Mental Health Apps

North Wales Raid Targets Illicit Mounjaro Sales as UK Cracks Down on Fake Weight-Loss Jabs

CDC Expands ByHeart Botulism Investigation as Cases Reach 51 Across 19 States

Texas Sues J&J and Kenvue, Alleging Deceptive Tylenol Marketing to Pregnant Women

Police Seek Woman After Lancashire Raid Seizes £32,000 in Suspected Fake Mounjaro and Ozempic

Counterfeit Botox Injections Tied to 28 Suspected Botulism Cases in County Durham

FDA Recalls Sacred Tattoo Ink Over Bacterial Contamination Risks

Coroner Highlights Suicide Risks of Antidepressants After Thomas Kingston's Death

Trump Nominates Dr. Marty Makary as FDA Commissioner

FDA Official Warns of Vaccine Challenges Under Trump Administration

FDA Recalls Duloxetine Over Cancer-Causing Chemical Concerns

Geron Shares Soar After FDA Approves New Blood Disorder Drug

FTC Targets 'Junk' Patents to Reduce Drug Prices, Enhances Competition

Biogen's Alzheimer's Drug Leqembi Exceeds Sales Expectations

FDA Approves First AI Tool for Sepsis Prediction